Cerebral Fat Embolism Syndrome in Homozygous Sickle Cell Disease Treated With Therapeutic Plasma Exchange and Simple

Tyler Vajdic1, Reuben Jacob1,2,3, Satheesh Chonat1,2

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

PubMed

Insights

Fat embolism syndrome (FES), a rare complication of sickle cell disease (SCD), can be life-threatening. Early combined treatment with transfusions and therapeutic plasma exchange (TPE) offers the most favorable outcomes for cerebral FES in SCD patients.

Area of Science:

  • Hematology
  • Neurology
  • Critical Care Medicine

Background:

  • Fat embolism syndrome (FES) is a rare but severe complication in sickle cell disease (SCD).
  • FES in SCD is associated with significant mortality and neurological impairment.
  • Cerebral involvement in FES presents diagnostic challenges.